ELEV - Financial Reports List - Elevation Oncology, Inc. - IntrinsicAlpha

Elevation Oncology, Inc. ELEV

Healthcare - Biotechnology - NASDAQ - US

$ 0.3781

-2.05 %

$ 22.4 M

Market Cap

-0.48

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-32.12%	-33.93%
Annual Report	FY	10-K	2024-12-31	0.00%	2.67%	1.63%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-21.11%	-21.14%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-3.47%	-11.48%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	37.24%	41.06%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	58.52%	57.13%
Annual Report	FY	10-K	2023-12-31	0.00%	51.93%	51.93%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	72.83%	71.66%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	48.78%	51.11%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	0.72%	3.59%

1